Nanosphere (Nanosphere) Total Operating Expense : $35.69 Mil (TTM As of Mar. 2016)

View and export this data going back to 2007. Start your Free Trial

What is Nanosphere Total Operating Expense?

Nanosphere's Total Operating Expense for the three months ended in Mar. 2016 was $8.66 Mil. Nanosphere's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2016 was $35.69 Mil.

Nanosphere Total Operating Expense Historical Data

The historical data trend for Nanosphere's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Total Operating Expense Chart

Nanosphere Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Total Operating Expense

Get a 7-Day Free Trial

36.17

34.44

37.31

43.48

36.42

Nanosphere Quarterly Data
	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16
Total Operating Expense	Get a 7-Day Free Trial															9.38	10.08	8.88	8.09	8.66

Nanosphere Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.69 Mil.

Nanosphere Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Nanosphere's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosphere (Nanosphere) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nanosphere Inc (NAS:NSPH) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nanosphere.us

Nanosphere, Inc., was incorporated in 1999 in Delaware. The Company develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation that is an advanced platform for genomic and protein testing. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System provides lower cost for laboratories already performing molecular diagnostic testing and enables smaller laboratories and hospitals without advanced diagnostic capabilities to perform genetic testing.

Executives

Michael James Ward	director	440 W. ONTARIO ST., CHICAGO IL 60654
Lorin Randall	director	C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
R. Erik Holmlin	director	4088 COMMERCIAL AVE., NORTHBROOK IL 60062
Gene S Cartwright	director	4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Mmcap International Inc. Spc	10 percent owner	C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD, 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348, GRAND CAYMAN E9 KY1-1108
Ann Wallin	officer: Interim CFO	4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Bruin Andre De	director
Sheli Z Rosenberg	director	C/O EQUITY GROUP INVESTMENTS, L.L.C., TWO NORTH RIVERSIDE PLAZA, SUITE 600, CHICAGO IL 60606
Chad A. Mirkin	director	4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Brookside Capital Management Llc	10 percent owner	C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Partners Fund Lp	10 percent owner	C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Investors L P	10 percent owner	C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Fund 2005, L.p.	10 percent owner	C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Partners 2005, L.p.	10 percent owner	C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Investors, Llc	10 percent owner	200 CLARENDON STREET, BOSTON MA 02116

Nanosphere (Nanosphere) Headlines

From GuruFocus

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus • 05-08-2009

New Optical Disks May Boost the Gold Nanoparticles Industry

By Alberto Abaterusso Alberto Abaterusso • 03-27-2018

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-06-2010

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-05-2009

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010